Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Greystone Research Associates | PRODUCT CODE: 1099303

Cover Image

PUBLISHER: Greystone Research Associates | PRODUCT CODE: 1099303

Subcutaneous Injection Devices for Biological Drugs

PUBLISHED:
PAGES: 250 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 3850
PDF (Site License)
USD 5500
PDF (Enterprise License)
USD 7000

Add to Cart

For drug self-administration devices, human engineering and user ergonomics are essential attributes that impact critical patient issues such as safety and patient compliance. While designers have acquired many powerful design tools during the past decade - tools that include 3D CAD design software and high-performance materials, design team have been increasingly relying on classic end user research to define the design targets for their projects. For drug self-administration devices, human engineering and user ergonomics are essential attributes that impact critical patient issues such as safety and patient compliance. While designers have acquired many powerful design tools during the past decade - tools that include 3D CAD design software and high-performance materials, design team have been increasingly relying on classic end user research to define the design targets for their projects.

What You Will Learn:

  • Provides detailed analysis of subcutaneous drug products, drug delivery and device strategies, and product development factors
  • Assesses key markets, market dynamics and market demographics
  • Analyzes therapeutic demand drivers and evaluates SC drug products in nine key therapeutic segments
  • Provides market data and forecasts to 2028
  • Profiles market sector participants, their product development activities, business strategies, and corporate alliances and affiliations
  • Assesses the importance of alliances and partnerships on subcutaneous drug product commercialization
  • Evaluates the impact of economic, technology, and regulatory factor
Product Code: EKD443R

Table of Contents

  • Executive Summary
  • The Market Opportunity
  • Delivery Market Dynamics
  • The Economics of Injectable Drugs
  • What's Driving the Growth in Injectable Devices?
  • Prefilled Syringes Proliferating
  • The Trend toward Self-Administration
  • Shifting Demographics
  • Innovation in Disposable Device Designs
  • Proliferation of Biological Drugs
  • Therapeutic Monoclonal Antibodies
  • Therapeutic Demand Drivers
  • Competitive Landscape
  • Risk Factors
  • Autoinjectors - Commercial Devices
  • Manual Injection Autoinjectors
  • Automated Injection Autoinjectors
  • Disposable Autoinjectors
  • AutoJect 2 (Owen Mumford)
  • SelfDose (West Pharmaceutical Services)
  • Flexi-Q PFS (Elcam Medical)
  • OTS Autoinjector (Consort Medical)
  • Pro-Ject (Aptar)
  • Consort Medical ASI
  • Ypsomed VarioJect
  • Rotaject Technology (SHL Medical)
  • Viscala Autoinjector (Consort Medical)
  • Flexi-Q HV (Elcam Medical)
  • Intevia (Becton Dickinson)
  • Antares Pharma Autoinjectors
  • Dali Medical Devices
  • Development-stage Autoinjectors
  • NIS Autoinjector (Midas Pharma)
  • ArQ - Bios (Oval Medical)
  • Wirelessly Enabled Autoinjectors
  • BETACONNECT (Bayer)
  • RebiSmart (Merck Serono)
  • Autoinjector Device Design Factors
  • Material Selection Issues
  • Part Counts and Device Cost
  • Safety Features
  • Needle Insertion Depth
  • Failsafe Activation
  • Dose Inspection/Injection Confirmation
  • Lyophilized Drugs/Reconstitution
  • Human Engineering/Ergonomics
  • Pen Injectors
  • Pen Injector Design Selection Factors
  • Standardized Pen Platforms
  • Haselmeier
  • Becton Dickinson
  • Owen Mumford
  • Autoject2
  • Ypsomed
  • SHL Medical
  • Custom Pen Designs
  • Reusable Pens
  • Dual Chamber Pens
  • Commercial Pen Products
  • Genotropin Pen
  • Humatro-Pen/Humatro Pen 3
  • Norditropin
  • Wearable Devices - Product Analysis and Assessments
  • Libertas (Becton Dickinson)
  • Patch Pump (Sensile Medical)
  • SmartDose (West Pharmaceuticals)
  • Neulasta OnPro Injector (Insulet/Amgen)
  • YpsoDose (Ypsomed)
  • Electronic Semi-disposable
  • E3D Patch Pump (Elcam)
  • Mechanical Disposable
  • enFuse (Enable Injections)
  • Captive Devices
  • sc2Wear Infusor (scPharmaceuticals)
  • PatchPump (SteadyMed)
  • Wireless Data
  • Key Therapeutic Sector Analysis
  • Anaphylaxis/Countermeasures
  • Autoimmune Diseases
  • Rheumatoid Arthritis
  • Psoriasis
  • Multiple Sclerosis
  • Exenatide (Byetta)
  • Bydureon
  • Pramlinitide (Symlin)
  • Abliglutide (Tanzeum)
  • Hepatitis
  • Hormones
  • Osteoporosis
  • Market Factors
  • Regulatory Issues
  • Device Branding
  • Patient Adherence and Ease of Use
  • Healthcare Economics
  • Company Profiles
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!